Senator Investment Group LP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 113 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Senator Investment Group LP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2023$3,355,000
-24.0%
500,0000.0%0.15%
-37.3%
Q1 2023$4,415,000
-42.2%
500,000
-50.0%
0.24%
-64.9%
Q4 2022$7,640,000
+7.3%
1,000,0000.0%0.69%
+6.2%
Q3 2022$7,120,000
-12.0%
1,000,0000.0%0.65%
+11.7%
Q2 2022$8,090,000
-41.7%
1,000,0000.0%0.58%
+34.7%
Q1 2022$13,880,000
-50.5%
1,000,0000.0%0.43%
-20.7%
Q4 2021$28,060,000
-17.4%
1,000,0000.0%0.54%
-6.9%
Q3 2021$33,990,000
-16.8%
1,000,0000.0%0.58%
-25.0%
Q2 2021$40,860,000
+1.5%
1,000,0000.0%0.78%
-6.3%
Q1 2021$40,260,000
-45.5%
1,000,000
-20.0%
0.83%
-40.7%
Q4 2020$73,912,000
-13.1%
1,250,000
-28.6%
1.40%
-43.7%
Q3 2020$85,102,000
+6.6%
1,750,000
+6.1%
2.48%
-10.1%
Q2 2020$79,827,000
-15.2%
1,650,000
-51.3%
2.76%
-19.0%
Q1 2020$94,121,000
-38.5%
3,388,085
-33.7%
3.41%
-18.6%
Q4 2019$152,984,000
+4.7%
5,113,0850.0%4.19%
+14.3%
Q3 2019$146,145,000
-30.4%
5,113,0850.0%3.67%
-4.9%
Q2 2019$209,918,0005,113,0853.86%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2019
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders